 |
|
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
Jang Ho Cho, Joon-Ho Shim, Sang Eun Yoon, Hee-Jin Kim, Sun-Hee Kim, Young Hyeh Ko, Seung-Tae Lee, Kihyun Kim, Won Seog Kim, Seok Jin Kim
Korean J Intern Med. 2021;36(3):668-678. Published online 2020 Aug 14 DOI: https://doi.org/10.3904/kjim.2019.367
|
|
Citations to this article as recorded by
 Tumor-Associated Macrophage (TAM)-Related Cytokines, sCD163, CCL2, and CCL4, as Novel Biomarkers for Overall Survival and Time to Treatment in Waldenstrom’s Macroglobulinemia: Emphasis on Asymptomatic WM
Alexandros Gkiokas, Mavra Papadatou-Gigante, Annita Ioanna Gkioka, Aspasia Koudouna, Thomai M. Tryfou, Alexandros Alexandropoulos, Vassiliki Bartzi, Nikolitsa Kafasi, Marie-Christine Kyrtsonis
Cells.2025; 14(4): 275. CrossRef Multicolor flow cytometry in the diagnosis of Waldenstrom macroglobulinemia
I. V. Galtseva, Yu. A. Tsoy, A. E. Grachev, N. M. Kapranov, K. A. Nikiforova, Yu. O. Davydova, A. A. Kulikov, E. E. Zvonkov, E. N. Parovichnikova
Oncohematology.2025; 20(1): 128. CrossRef Clinical Characteristics and Treatment Outcomes of Patients with Waldenstrom Macroglobulinemia
Gaurav Prakash, Charanpreet Singh, Pradeep Reddy, K. S. Lekshmon, Arihant Jain, Alka Khadwal, Pulkit Rastogi, Nabhajit Mallik, Amanjit Bal, Pankaj Malhotra
Indian Journal of Hematology and Blood Transfusion.2025;[Epub] CrossRef Waldenström Macroglobulinemia: The Role of TP53 Mutations in Disease Progression and Therapeutic Response
Despoina Dimitria Kampitsi, Paschalis Theotokis, Paschalis Evangelidis, Soultana Meditskou, Maria Eleni Manthou, Iasonas Dermitzakis
Current Issues in Molecular Biology.2025; 47(4): 260. CrossRef Antineoplastic drugs
Reactions Weekly.2021; 1870(1): 38. CrossRef
|